Nourah A. Al Zahrani

Dr. Nourah A. Al Zahrani

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2020 in Molecules
Verified
Journal Article
Open access
PDF file
NZNourah A. Al Zahrani
Nourah A. Al Zahrani
Reda El-ShishtawyReda El-Shishtawy
Reda El-Shishtawy
MEMahmoud M. Elaasser
Mahmoud M. Elaasser
Abdullah M. AsiriAbdullah M. Asiri
Abdullah M. Asiri
Based on reported results for the potential medicinal impact of phenothiazine core, as well as the chalcone skeleton that is widely present in many natural products, together with their reported bioactivities, the present work was aimed at combining both moieties in one molecular skeleton and to synthesize and characterize a novel series of chalone-based phenothiazine derivatives. For this purpose, 2-acetylphenothiazine was N-alkylated, followed by the Claisen-Schmidt reaction to produce the chalcones with good yield. Antioxidant activity, as evaluated by 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging, was assessed to determine if their antioxidant potential was comparable with ascorbic acid, and attributable to the phenothiazine core. Screening anticancer activities of the synthesized chalone-based phenothiazine derivatives against human breast cancer cell line MCF-7 cells, and human hepatocellular carcinoma HepG-2 cells, compared with standard drugs cisplatin and doxorubicin, was evaluated. The results revealed that compounds 4a, 4b, 4d, 4h, 4j, 4k, 4m, 4o, and 4p were good against human hepatocellular carcinoma HepG-2 cells, and among these compounds 4b and 4k were the most effective compounds, with IC50 values of 7.14 μg/mL and 7.6 1 μg/mL, respectively. On the other hand, compounds 4a, 4b, 4k, and 4m were good against human breast cancer cell line MCF-7 cells and, among these compounds, 4k and 4b were the most effective compounds, with IC50 values of 12 μg/mL and 13. 8 μg/mL, respectively. The overall results suggest that these compounds could, potentially, be further modified for the formation of more potent antioxidant and anticancer agents.

23 April 2024 in Egyptian Journal of Chemistry
Verified
Journal Article
Closed access
NZNourah A. Al Zahrani
Nourah A. Al Zahrani
REReda M. El‐Shishtawy
Reda M. El‐Shishtawy
Herein, the design, synthesis, and characterization of four novel galloyloxadiazole hybrids are described. Compounds were evaluated in vitro as antioxidant agents by DPPH assay in comparison with reference antioxidants (ascorbic acid and butylated hydroxytoluene (BHT)) (scavenging of free radical 2,2-diphenyl-1-picrylhydrazyl DPPH). It was found that, interestingly, all compounds showed very strong antioxidant activity, even more than the water-soluble ascorbic acid. Such strong activity is related to the gallic acid moiety, as it has three dissociable OH groups via hydrogen atom transfer. The overall results suggest that these compounds could, potentially, be further modified for the formation of more potent antioxidant, and more biological studies are under investigation. These studies should be conducted in the following study.